Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Myra Rusten"'
Autor:
Kendra A. Hyland, R. Scott McIvor, Jason B. Bell, David W. Hunter, Erik R. Olson, Roland Gunther, Perry B. Hackett, Elena L. Aronovich, Myra Rusten
Publikováno v:
Human Gene Therapy. 28:541-550
The Sleeping Beauty transposon system has been extensively tested for integration of reporter and therapeutic genes in vitro and in vivo in mice. Dogs were used as a large animal model for human therapy and minimally invasive infusion of DNA solution
Autor:
Elena L. Aronovich, Myra Rusten, Jason B. Bell, Bryan C. Hall, David W. Hunter, N. Matthew Ellinwood, R. Scott McIvor, Erik R. Olson, Perry B. Hackett, Kendra A. Hyland
Publikováno v:
Human gene therapy. 28(7)
The non-viral, integrating Sleeping Beauty (SB) transposon system is efficient in treating systemic monogenic disease in mice, including hemophilia A and B caused by deficiency of blood clotting factors and mucopolysaccharidosis types I and VII cause
Publikováno v:
Journal of vascular and interventional radiology : JVIR. 24(10)
Purpose To assess the level of occlusion and arterial distribution of calibrated bioresorbable microspheres (BRMS-I and BRMS-II) compared with tris-acryl gelatin microspheres (TGMS) after renal embolization. Materials and Methods Six rabbits underwen
Autor:
R. Scott McIvor, Elena L. Aronovich, Myra Rusten, Chester B. Whitley, Kendra A. Hyland, David W. Hunter, Perry B. Hackett, Erik R. Olson, Jason B. Bell, N. Matthew Ellinwood, Bryan C. Hall
Publikováno v:
Molecular Therapy. 24:S174
The non-viral integrating vector the Sleeping Beauty (SB) transposon system is efficient in treating systemic monogenic diseases in mice including mucopolysaccharidosis (MPS) types I and VII caused by α-iduronidase (IDUA) and β-glucuronidase (GUSB)